Epidemiological trends in nontuberculous mycobacterial infection among people with cystic fibrosis in Germany

被引:4
|
作者
Steindor, Mathis [1 ]
Hafkemeyer, Sylvia [2 ]
Ruckes, Christian [3 ]
Stehling, Florian [1 ]
Naehrlich, Lutz [4 ]
Ringsha, Felix C. [5 ,6 ]
机构
[1] Univ Duisburg Essen, Childrens Univ Hosp Essen, Pediat Pulmonol & Sleep Med, Essen, Germany
[2] Mukoviszidose Inst gGmbH, Bonn, Germany
[3] Johannes Gutenberg Univ Mainz, Univ Med Ctr Johannes Gutenberg, Interdisciplinary Ctr Clin Trials Mainz, Mainz, Germany
[4] Justus Liebig Univ Giessen, Dept Pediat, Giessen, Germany
[5] German Ctr Lung Res DZL, Hannover Med Sch & Biomed Res End Stage & Obstruct, Dept Resp Med, Hannover, Germany
[6] European Reference Network Rare & Complex Resp Dis, Frankfurt, Germany
关键词
Cystic fibrosis transmembrane conductance; regulator; Epidemiology; Germany; Mycobacterium abscessus; Mycobacterium avium; Registries; PULMONARY-DISEASE; SCREENING PRACTICES; PREVALENCE;
D O I
10.1016/j.ijid.2023.01.032
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: People with cystic fibrosis (pwCF) are at risk for infection with nontuberculous mycobacteria (NTM). The epidemiology and screening practice of NTM among pwCF in Germany are largely unknown and require investigation.Methods: We analyzed the data of the German Cystic Fibrosis Registry from 2016 to 2020 for NTM. The annual prevalence and incidence of any NTM, Mycobacterium abscessus complex (MABC), Mycobacterium avium complex (MAC), Mycobacterium gordonae , and other mycobacteria were determined and correlated to patient characteristics. Patients with incident MABC and MAC infection were compared.Results: The annual NTM prevalence and incidence remained stable between 7.53% and 8.76%, as well as 3.31% and 4.95%, respectively, among the approximately 60 0 0 registry participants. MABC was the most common NTM, whereas only the prevalence of MAC increased slightly. In each year, only about one-third of all patients were screened for NTM. An association between NTM infections and Aspergillus fumigatus infection and/or allergic bronchopulmonary aspergillosis was observed. On average, patients with incident MAC infection were older than patients with MABC infection.Conclusion: The NTM burden in pwCF in Germany remained unchanged between 2016 and 2020. MABC was the dominant species detected, whereas only MAC infections increased with time and patient age. The previously observed association of Aspergillus fumigatus and NTM was reaffirmed. Awareness of NTM needs to be improved.(c) 2023 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
引用
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [31] Non-tuberculous mycobacterial infection in patients with non-cystic fibrosis bronchiectasias
    Martinez-Ceron, E.
    Prados, C.
    Gomez-Carrera, L.
    Cabanillas, J. J.
    Lopez-Lopez, G.
    Alvarez-Sala, R.
    REVISTA CLINICA ESPANOLA, 2012, 212 (03): : 127 - 130
  • [32] Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010–2019)
    Julia E. Marshall
    Rachel A. Mercaldo
    Ettie M. Lipner
    D. Rebecca. Prevots
    BMC Infectious Diseases, 23
  • [33] Prospective healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (pHALT NTM) study: Rationale and study design
    Gross, Jane E.
    Caceres, Silvia
    Poch, Katie
    Epperson, L. Elaine
    Hasan, Nabeeh A.
    Jia, Fan
    Calado Nogueira de Moura, Vinicius
    Strand, Matthew
    Lipner, Ettie M.
    Honda, Jennifer R.
    Strong, Michael
    Davidson, Rebecca M.
    Daley, Charles L.
    Nick, Jerry A.
    PLOS ONE, 2023, 18 (12):
  • [34] Detecting clusters of high nontuberculous mycobacteria infection risk for persons with cystic fibrosis - An analysis of US counties
    Mercaldo, Rachel A.
    Marshall, Julia E.
    Prevots, D. Rebecca
    Lipner, Ettie M.
    French, Joshua P.
    TUBERCULOSIS, 2023, 138
  • [35] Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosis
    Kerem, Eitan
    Orenti, Annalisa
    Zolin, Anna
    Annicchiarico, Luigi
    Drevinek, Pavel
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (02) : 334 - 343
  • [36] Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010-2019)
    Marshall, Julia E.
    Mercaldo, Rachel A.
    Lipner, Ettie M.
    Prevots, D. Rebecca.
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [37] Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis
    Frost, Freddy
    Shaw, Matthew
    Nazareth, Dilip
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (12):
  • [38] Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis
    Frost, Freddy
    Shaw, Matthew
    Nazareth, Dilip
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (06):
  • [39] Cystic fibrosis mortality trends in Spain among infants and young children: 1981–2004
    Enrique Ramalle-Gomara
    Milagros Perucha
    María-Ángeles González
    Carmen Quiñones
    Jesús Andrés
    Manuel Posada
    European Journal of Epidemiology, 2008, 23 : 523 - 529
  • [40] Analysis of epidemiological trends in human papillomavirus infection among gynaecological outpatients in Hangzhou, China, 2011-2015
    Qian, Lili
    Zhang, Yu
    Cui, Dawei
    Lou, Bin
    Chen, Yimin
    Yu, Ying
    Liu, Yonglin
    Chen, Yu
    BMC INFECTIOUS DISEASES, 2017, 17